*By Christian Smith*
After an overdose earlier this week, Demi Lovato's life was reportedly saved by Narcan, a nasal administrator of naloxone that counteracts the effects of opioids. When administered quicklyーthrough either nasal mist or injectionーnaloxone can temporarily halt an overdose, allowing EMTs enough time to respond. The medication is available without a prescription in 49 states, and the generic version costs about $20 per dose.
But all merits aside, is the drug's accessibility enabling addicts to push their limits?
Dr. Roger Crystal, the lead inventor of Narcan and CEO of Opiant Pharmaceuticals, says there's little evidence to support that concern.
"Addiction like any kind of chronic disease is something you can control using better medication, but ultimately you can't cure," Crystal told Cheddar. "To think about an opioid addict behaving rationally and saying, 'well because I have access to Narcan I'll shoot more heroin, inject more heroin' there's no proof for that whatsoever."
Naloxone is considered some of the best ammunition on the front lines of America's growing opioid epidemic. A reported 2 million Americans have an addition to opioidsーand the number isn't going down. U.S. Surgeon General Jerome Adams [issued an advisory](https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html) in April urging anyoneーand their close family and friendsーwho uses painkillers, heroin, fentanyl, or other opioids to carry naloxone in case of an emergency.
Crystal isn't stopping at Narcan: he told Cheddar he's also developing a heroin vaccine, suggesting the inventor has lofty ambitions for the future of overdose prevention.
Although Crystal may be aware of lingering ethical concerns, he doesn't think they dwarf his mission. After all, Lovato has him to thank.
"Putting it in the hands of everyone and anyone is critical," Crystal said.
For more on this story, [click here](https://cheddar.com/videos/how-one-pharmaceutical-company-is-fighting-the-opioid-epidemic).
The theme of Bill and Melinda Gates' annual letter for 2019 is "surprise." The letter, released Tuesday, acts as a roadmap for how the Gates Foundation plans to invest in technology that will help make the world a better place in the years to come. And, as Melinda Gates told Cheddar in an interview, it starts with poop.
There's a dearth of research to back up the abundance of miraculous health claims tied to CBD ー but that won't stop celebrities from endorsing it. CBD, or cannabidiol, is a component of cannabis or hemp with little to no psychotropic effects. It is purported to have an array of applications to treat everything from epilepsy to anxiety, pain, depression, and sleeplessness. When Congress and President Trump signed the latest version of the Farm Bill into effect, they also legalized hemp, and thereby CBD derived from hemp.
More than 50 years after the psychedelic Summer of Love, psilocybin, the psychoactive component in magic mushrooms, is having a moment. Researchers at leading universities have been conducting research on the purported medical benefits of mushrooms for years, but as studies yield promising results, the opioid epidemic persists and sentiment warms toward cannabis, mushrooms are earning a lot more attention. Lawmakers and psychotropic advocates have concurrently advanced separate measures in Oregon, Colorado, and, most recently, Iowa, that attempt to loosen restrictions on these hallucinogenic fungi.
These are the headlines you Need 2 Know for Thursday, Feb. 7, 2019.
These are the headlines you Need 2 Know for Wednesday, Feb, 6, 2019.
Millions of people around the world are getting ready for the Super Bowl on Sunday. And while the day is all fun and games, there's still a serious discussion happening about player safety. Now, two leading sports brands have teamed up to design new, state-of-the-art equipment using 3D printing. Joe DeSimone, co-founder and CEO of Carbon, stopped by Cheddar with more on how technology is making football more safe, head to toe.
These are the headlines you Need 2 Know for Friday, Feb. 1, 2019.
These are the headlines you Need 2 Know for Wednesday, Jan. 30, 2019.
Canopy Growth is planning its entry to the U.S. on the back of the new Farm Bill ー and aims to establish a hemp "hub" in New York, according to CEO Bruce Linton."New York is setting up a pretty progressive approach and we have an earlier first license under that system so we can actually create a hub," Linton told Cheddar on Tuesday.
Meditation app Headspace is zen about its future. Coming off a profitable year in 2018, with more than $100 million in revenue, CEO and co-founder Rich Pierson told Cheddar on Monday that the company is looking to continue its domination of the digital meditation space by pushing into healthcare and international markets.
